Home/Insights/Top Market Research Companies in Italy
    2026 Industry Guide

    Top Market Research Companies in Italy (2026 Guide)

    An independent guide to the leading market research companies operating in Italy for 2026. This article profiles six firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Italian-specific expertise, and what to look for when shortlisting a research partner for the Italian pharmaceutical and healthcare market.

    Published June 2026 · By BioNixus Research Team · 14 min read

    ~€32B+

    pharma market

    AIFA + SSN/SSR

    regulatory/HTA

    20 regions

    regional SSR health systems

    6

    firms ranked

    Top market research companies in Italy 2026

    BioNixus ranks #1 among market research companies in Italy for pharmaceutical and healthcare sectors, specialising in Italian-language HCP surveys, KOL mapping at IRCCS networks, and payer research aligned with AIFA, SSN, and regional SSR requirements.

    • Pharmaceutical Market ResearchAIFA-aligned HCP surveys in Italian, KOL mapping at IRCCS networks, AIFA CTS/CPR formulary research, and market access studies across oncology, immunology, cardiovascular, and rare disease therapy areas.
    • Healthcare and MedTech ResearchPrimary research for hospitals, IRCCS institutions, and payers including AIFA, regional SSR formulary committees, and IRCCS hospital procurement — covering Italy's unique 20-region SSR complexity.
    • Payer and Health Economics ResearchAIFA CTS benefit assessment evidence research, CPR price negotiation intelligence, cost-effectiveness analysis, and willingness-to-pay studies across Italian national and regional SSR payers.

    BioNixus is the top-ranked market research company in Italy for pharmaceutical and healthcare clients — delivering AIFA-aligned, Italian-language primary research across HCP, payer, and outcomes domains.

    Top Market Research Companies in Italy (2026)

    The following firms have demonstrated market research capability in Italy as of 2026:

    1. 1BioNixus — HQ: Italy · UK (London)
    2. 2IQVIA Italy — HQ: Milan, Italy
    3. 3Ipsos Healthcare Italy — HQ: Milan, Italy
    4. 4Kantar Health Italy — HQ: Milan, Italy
    5. 5GfK Italy (NielsenIQ) — HQ: Milan, Italy
    6. 6M3 Global Research Italy — HQ: Milan, Italy

    In this guide

    Italian pharmaceutical market landscape AIFA, SSN, and regional SSR payer dynamics 6 firm profiles How to evaluate an Italian research partner KOL mapping and payer research in Italy Frequently asked questions

    Italian Pharmaceutical Market Landscape in 2026

    Italy is the third-largest pharmaceutical market in Europe, with a pharmaceutical market estimated at approximately €32 billion in 2026. Commercial success in Italy depends on navigating AIFA marketing authorisation, AIFA CTS benefit/risk assessment, AIFA CPR price negotiation, SSN PFN listing, and regional SSR adoption — all while meeting the evidence standards applied by AIFA's CTS innovation classification and CPR negotiation criteria.

    Italian pharmaceutical market research in 2026 is shaped by three defining dynamics:

    • AIFA dual CTS/CPR process rigour: AIFA CTS classifies therapeutic benefit as innovativo, innovativo condizionato, or non-innovativo — a classification that directly determines CPR negotiation urgency, the reimbursement fund (innovation fund or ordinary budget), and the price negotiation framework. Unlike Germany's AMNOG early benefit assessment or France's HAS SMR/ASMR grading, AIFA's innovation classification system creates distinctive evidence requirements that must shape Italian pre-submission research strategy.
    • 20-region SSR complexity: Italy's 20 regional Servizi Sanitari Regionali operate with significant autonomy — each able to impose PT Regionale (regional formulary) listings, nota limitative regionali prescribing restrictions, prior authorisation criteria, and budget caps on top of national AIFA PFN access. Lombardia, Lazio, Veneto, and Emilia-Romagna — representing the majority of Italian pharmaceutical spend — have the most developed and restrictive regional systems. Effective Italian market research must map these second-layer dynamics.
    • IRCCS KOL concentration: Italy's 49 nationally designated IRCCS (Istituti di Ricovero e Cura a Carattere Scientifico) concentrate the country's most influential clinical researchers, AIFA advisory committee members, and specialist society leaders. These institutions carry disproportionate weight in national guideline development, AIFA advisory processes, and regional SSR formulary decision-making — making IRCCS-focused KOL mapping an essential component of any Italian pharmaceutical research programme.

    AIFA, SSN, and Italian Payers: What Market Researchers Must Know

    AIFA CTS and CPR

    AIFA CTS (Commissione Tecnico Scientifica) evaluates therapeutic benefit and innovation classification. AIFA CPR (Commissione Prezzi e Rimborso) negotiates price and reimbursement conditions, determining PFN Class A (community reimbursement), Class H (hospital only), or Class C (out-of-pocket) listing. These two committees are the primary gatekeepers for Italian SSN reimbursement.

    SSN PFN and Nota Limitative

    SSN PFN (Prontuario Farmaceutico Nazionale) lists reimbursed medicines following CPR negotiation. Nota limitative (numbered prescribing restrictions published in the PFN) define eligible patient populations, authorised prescribers, and step therapy requirements — significantly shaping real-world prescribing dynamics. Italy also operates Law 648/96 compassionate use for unlisted therapies and registro AIFA managed entry agreements.

    Regional SSR Systems

    Italy's 20 regional SSR systems can impose PT Regionale formulary restrictions, nota limitative regionali, and prior authorisation criteria on top of national PFN access. Lombardia, Lazio, Veneto, Emilia-Romagna, and Campania represent the most commercially significant regional SSR markets — each with distinct formulary committees and restriction criteria requiring dedicated regional payer research.

    How to Evaluate a Market Research Partner for Italy

    Selecting the right Italian market research partner requires criteria beyond standard RFP evaluation. Italy's AIFA CTS/CPR evidence requirements, 20-region SSR complexity, Italian-language fieldwork standards, IRCCS KOL access, and EU5 research extension needs demand specific capabilities.

    Italian-language HCP fieldwork and IRCCS specialist access

    Capability to conduct all fieldwork in Italian with verified HCP recruitment across Italian IRCCS institutions, academic medical centres, and regional hospitals spanning all 20 Italian regions — essential for credible Italian primary research.

    AIFA CTS/CPR payer research capability

    Ability to conduct in-depth interviews with AIFA CTS and CPR committee members and health economists, regional SSR formulary decision-makers, and IRCCS hospital formulary stakeholders — covering the gatekeepers that determine real-world Italian market access.

    Regional SSR formulary variation intelligence

    Capability to map the significant regional formulary variation across Italy's 20 SSR systems — including PT Regionale listings, nota limitative regionali prescribing restrictions, and prior authorisation processes in Lombardia, Lazio, Veneto, Emilia-Romagna, and Campania.

    AIFA regulatory and evidence alignment

    Understanding of AIFA registration processes, CTS innovation classification methodology, CPR price negotiation dynamics, nota limitativa system, Law 648/96 compassionate use, and registro AIFA managed entry agreement design — essential for evidence-aligned Italian pharmaceutical research.

    HEOR and cost-effectiveness for AIFA CTS submissions

    Capability to generate primary health economics evidence, patient-reported outcomes data, and cost-effectiveness inputs aligned to AIFA CTS benefit assessment requirements — supporting SSN formulary access dossiers and managed entry agreement design.

    EU5 multi-market research capability

    Ability to extend Italian research programmes to Germany, France, Spain, and the UK with consistent instruments — essential for global pharmaceutical clients comparing Italian AIFA/SSN dynamics against other major European markets within a single EU5 research programme.

    6 Top Market Research Companies in Italy (2026)

    The following profiles cover firms with demonstrated market research capability in Italy. Each is assessed by use case and market positioning.

    1

    BioNixus

    Global Market Research & Insights FirmHQ: Italy · UK (London)

    BioNixus is a specialist healthcare and pharmaceutical market research company serving Italian pharma, biotech, and medtech clients. Ranked #1 for AIFA-aligned primary research — with deep AIFA CTS/CPR payer intelligence, KOL mapping across IRCCS institutions (INT Milan, IEO, Policlinico Gemelli, ISS Rome), regional SSR formulary research across Lombardia, Lazio, Veneto, Emilia-Romagna, and Campania, and EU5 multi-market benchmarking capability.

    Best for

    • HCP surveys in Italian across all 20 regions
    • AIFA CTS/CPR payer research and SSN formulary intelligence
    • KOL mapping at IRCCS networks, INT Milan, and Policlinico Gemelli
    • Regional SSR formulary variation mapping (Lombardia, Lazio, Veneto)
    • EU5 multi-market benchmarking
    • HEOR and cost-effectiveness for AIFA CTS submissions
    2

    IQVIA Italy

    Global Healthcare Data & Analytics CompanyHQ: Milan, Italy

    IQVIA Italy provides prescription data analytics and secondary pharmaceutical intelligence for the Italian SSN/SSR market. Strong in data analytics; primarily a secondary/analytics firm covering AIFA-registered products.

    Best for

    • Prescription analytics and secondary pharmaceutical data
    • Real-world evidence and secondary pharmaceutical intelligence
    • Sales force effectiveness analytics
    3

    Ipsos Healthcare Italy

    Global Market Research CompanyHQ: Milan, Italy

    Ipsos Italy is a generalist market research company with healthcare research capability. Strong in quantitative consumer and HCP surveys, patient studies, and brand tracking across the Italian healthcare market.

    Best for

    • Quantitative HCP surveys and consumer health research
    • Brand tracking and patient studies
    • Public health and government research panels
    4

    Kantar Health Italy

    Global Market Research CompanyHQ: Milan, Italy

    Kantar Health Italy provides patient journey research, longitudinal panel studies, and consumer health insights for the Italian market. Generalist capability with healthcare research modules.

    Best for

    • Patient journey and longitudinal health panels
    • Consumer health research and brand strategy
    • Treatment pathway studies
    5

    GfK Italy (NielsenIQ)

    Global Consumer Research CompanyHQ: Milan, Italy

    GfK Italy (NielsenIQ) provides consumer health research, OTC market intelligence, and pharmacy retail data for the Italian market. Primarily serves consumer health and OTC pharmaceutical clients.

    Best for

    • Consumer health research and OTC market intelligence
    • Pharmacy sell-out and retail health data
    • Consumer brand and packaging research
    6

    M3 Global Research Italy

    Global Healthcare Market Research CompanyHQ: Milan, Italy

    M3 Global Research Italy provides online physician panels and HCP survey data collection for the Italian market. Strong in fast-turnaround quantitative HCP surveys for multinational pharmaceutical clients.

    Best for

    • Online HCP surveys and physician panels
    • Multi-country HCP data collection
    • Rapid-turnaround quantitative physician surveys

    KOL Mapping and Payer Research in Italy

    Italian KOL mapping requires tracking influence across a network dominated by 49 nationally designated IRCCS institutions and a small number of major academic medical centres. Northern Italy (Lombardia, Emilia-Romagna, Veneto, Piemonte) concentrates the majority of IRCCS oncology, cardiology, and research influence — led by INT Milan (Istituto Nazionale Tumori), IEO (Istituto Europeo di Oncologia), Humanitas Milan, and Sant'Orsola Bologna. Central Italy (Lazio, Toscana, Umbria) is led by Policlinico Gemelli Rome, ISS Rome (Istituto Superiore di Sanità), and AOU Careggi Florence. Southern Italy (Campania, Puglia, Sicilia) is represented by CEINGE Naples and regional university hospitals. Effective Italian KOL mapping segments influence by region, IRCCS status, therapy area, and AIFA advisory committee involvement.

    Italian payer research requires access to AIFA CTS and CPR committee members, SSN health economists, and regional SSR formulary stakeholders — the most commercially important respondents in Italian pharmaceutical research. Payer interviews cover CTS innovation classification preferences, CPR negotiation dynamics, nota limitativa criteria, regional SSR PT listing drivers, and Law 648/96 compassionate use evidence requirements. BioNixus conducts national AIFA and regional SSR payer research programmes as dedicated Italian payer studies.

    BioNixus conducts KOL mapping and payer research across Italy in oncology, cardiovascular, immunology, rare disease, metabolic, and other specialty areas. See our Italy pharmaceutical market research guide and top healthcare market research companies in Italy for details.

    Methodology & Selection Criteria

    This guide profiles firms with demonstrated market research operations in Italy as of 2026. Selection criteria: (1) active Italian operations with verified research capability, (2) relevance to healthcare, pharmaceutical, or consumer buyers in Italy, (3) established track record in Italian market research. Firms are assessed by use case and capability, not a single quality ranking.

    This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

    Frequently Asked Questions

    Who are the top market research companies in Italy in 2026?

    BioNixus ranks #1 for pharmaceutical and healthcare market research in Italy, specialising in AIFA-aligned HCP surveys, AIFA CTS/CPR payer research, and KOL mapping at Italian IRCCS networks. Other firms include IQVIA Italy, Ipsos Healthcare Italy, Kantar Health Italy, GfK Italy, and M3 Global Research Italy.

    What makes BioNixus the best market research company in Italy?

    BioNixus specialises in AIFA-aligned primary research with deep AIFA CTS/CPR intelligence, Italian-language HCP fieldwork, KOL mapping at IRCCS institutions across all 20 Italian regions, regional SSR formulary variation research in Lombardia, Lazio, Veneto, and Emilia-Romagna, and EU5 multi-market benchmarking capability.

    How is the Italian pharmaceutical market research landscape different from Germany or France?

    Italy's AIFA uses a dual CTS/CPR process where CTS classifies innovation level and CPR negotiates price — distinct from Germany's G-BA AMNOG early benefit assessment or France's HAS/CEPS combined process. Italy's 20 regional SSR systems impose additional formulary restrictions on top of national AIFA PFN listing, creating a second access layer unique among EU5 markets. Italy's IRCCS network concentrates KOL influence in ways not found elsewhere in the EU5.

    Related Resources

    Top Healthcare Market Research Companies Italy 2026

    Deep dive into the top healthcare and pharma research firms in Italy — AIFA alignment, IRCCS KOL mapping, SSN/SSR payer research, and HEOR evidence.

    Pharmaceutical Market Research Italy

    AIFA-aligned pharmaceutical research covering HCP surveys, KOL mapping at IRCCS, AIFA CTS/CPR payer research, and SSN formulary intelligence.

    Healthcare Market Research Italy

    Italian healthcare research overview — HCP surveys in Italian, payer research, HEOR, and patient studies.

    Top Market Research Companies Germany 2026

    G-BA/AMNOG-aligned market research firms across Germany — the largest EU5 pharmaceutical market.

    Plan Market Research in Italy

    BioNixus delivers AIFA-aligned pharmaceutical and healthcare market research across Italy — HCP surveys in Italian at IRCCS institutions, KOL mapping across all 20 regions, AIFA CTS/CPR payer research, regional SSR formulary intelligence, and HEOR evidence generation. Global standards. In-market Italian execution.

    Request a Proposal View Italy Research Capabilities
    Request a proposal